MedPath

Web-based Interventions on Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Children

Not Applicable
Completed
Conditions
Childhood Obesity
NAFLD
Web
Interventions
Other: web-based intervention
Registration Number
NCT05527938
Lead Sponsor
Shaoxing Maternity and Child Health Care Hospital
Brief Summary

The web-based continuity of care intervention model to provide comprehensive nursing interventions for obese children with NAFLD, always tracking their performance status, enabling them to grasp the knowledge of healthy weight loss, develop good lifestyle habits, and reduce their weight, thus reducing the incidence of NAFLD in children.

Detailed Description

The web-based continuity of care intervention model to provide comprehensive nursing interventions for obese children with NAFLD, always tracking their performance status, enabling them to grasp the knowledge of healthy weight loss, develop good lifestyle habits, and reduce their weight, thus reducing the incidence of NAFLD in children.The primary outcome are serum biomarkers such as alanine aminotransferase (ALT) and gamma-glutamyl transferase (GGT) . Second outcomes are: aspartate aminotransferase, and liver imaging (liver ultrasound and magnetic resonance imaging), BMI, waist-to-hip ratio and quality of life. In addition, socio-demographic characteristics such as age, gender and ethnicity will be recorded. All outcomes were measured at baseline, week 4, week 16, week 24, week 36, and week 48 to determine the trajectory of change in outcome variables over intervention process.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
85
Inclusion Criteria
  • The clinical diagnosis of Nonalcoholic Fatty Liver Disease
Exclusion Criteria
  • Patients do not agree to participate
  • participate in other health intervention programs now

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
web-based interventionweb-based intervention1. Establishing management teams. 2. Establishment of a nursing intervention team. 3. Daily uploading of health intervention records 4. Regularly delivering related health knowledge. 5. Home visiting 6. Psychological guidance.
Primary Outcome Measures
NameTimeMethod
The change of alanine aminotransferase(ALT)and gamma-glutamyl transferase(GGT)Change from Baseline ALT and GGT at 48 weeks

The primary outcome are serum biomarkers such as alanine aminotransferase (ALT) and gamma-glutamyl transferase (GGT) .

Secondary Outcome Measures
NameTimeMethod
The change of BMIChange from Baseline BMI at 48 weeks

Fourth outcome is BMI

The change of waist-to-hip ratioChange from Baseline waist-to-hip ratio at 48 weeks

Fifth outcome is waist-to-hip ratio

The change of quality of lifeChange from Baseline quality of life at 48 weeks

Sixth outcome is quality of life

The change of aspartate aminotransferaseChange from Baseline aspartate aminotransferase at 48 weeks

Second outcome is aspartate aminotransferase

The change of liver imagingChange from Baseline liver imaging at 48 weeks

Third outcome is liver imaging

Trial Locations

Locations (1)

Caixia Tian

🇨🇳

Shaoxing, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath